Innovation Stage: Cell Therapy Highlight

Innovation Stage: Cell Therapy Highlight

Friday, January 19, 2024 9:00 AM to 10:00 AM · 1 hr. (US/Eastern)
Innovation Stage
Presentation
Innovation Zone

Information

Chair

Representative from Phacilitate

9am Presentation: A Novel Platform For The Development Of Programmable Advanced Therapies

Laverock Therapeutics

9.10am Presentation: The Mygotic Process tm -The Next Advancement in Autologous Totipotent Stem Cells from Somatic Cells

Akeso Therapeutics

9.20am Presentation: i-body® enabled next generation advanced therapies

Adalta

09.30am Presentation

Ossium Health

9.40am Presentation: Translating Personalized Tissue Engineering to Common Diseases at Scale

Muvon Therapeutics

Modality
Cell Therapy
AdAltaDeveloping innovative solutions to debilitating diseases AdAlta’s i-body® drug discovery platform goes where antibodies do not, to create new options for debilitating diseases Using i-bodies – with antibody features at a fraction of the size Developing next generation protein and cell therapies – focused on fibrosis and immuno-oncology Lead asset AD-214 – first in class product for treating fibrotic diseases i-CAR-T cell therapies (reprogramming immune cells) – providing new hope for patients with solid tumours i-PET imaging – helping cancer patients know early if their immunotherapy is working

Log in